[go: up one dir, main page]

TR200001867T2 - 1-Metil-5-p-topluoilpirol-2-asetamidoasetik asit guaiasil esterin yeni kristalin polimorfik biçimi - Google Patents

1-Metil-5-p-topluoilpirol-2-asetamidoasetik asit guaiasil esterin yeni kristalin polimorfik biçimi

Info

Publication number
TR200001867T2
TR200001867T2 TR2000/01867T TR200001867T TR200001867T2 TR 200001867 T2 TR200001867 T2 TR 200001867T2 TR 2000/01867 T TR2000/01867 T TR 2000/01867T TR 200001867 T TR200001867 T TR 200001867T TR 200001867 T2 TR200001867 T2 TR 200001867T2
Authority
TR
Turkey
Prior art keywords
guaiasil
ester
methyl
colloylpyrrole
new crystalline
Prior art date
Application number
TR2000/01867T
Other languages
English (en)
Inventor
Anzalone Sergio
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite Spa
Medosan Industrie Biochimiche Riunite S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite Spa, Medosan Industrie Biochimiche Riunite S.R.L. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite Spa
Publication of TR200001867T2 publication Critical patent/TR200001867T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/323—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)

Abstract

1-metil-5-p-toluoilpirol-2-asetamidoasetik asit guaiasil esterin yeni bir kristalin biçimi, bunun hazirlanmasi için bir süreç ve ates önleyici, analjestik farmasötik bilesikler ve aynisini içeren antipiretik etkinlik.
TR2000/01867T 1997-12-24 1998-12-16 1-Metil-5-p-topluoilpirol-2-asetamidoasetik asit guaiasil esterin yeni kristalin polimorfik biçimi TR200001867T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000811A IT1297140B1 (it) 1997-12-24 1997-12-24 Forma cristallina del guaiacil estere dell'acido l-metil-5-p-toluoil- pirrol-2-acetammidoacetico, procedimento per la sua preparazione e

Publications (1)

Publication Number Publication Date
TR200001867T2 true TR200001867T2 (tr) 2000-12-21

Family

ID=11405418

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01867T TR200001867T2 (tr) 1997-12-24 1998-12-16 1-Metil-5-p-topluoilpirol-2-asetamidoasetik asit guaiasil esterin yeni kristalin polimorfik biçimi

Country Status (21)

Country Link
US (1) US6288241B1 (tr)
EP (1) EP1082304B1 (tr)
JP (1) JP4693236B2 (tr)
KR (1) KR100554704B1 (tr)
CN (1) CN1200930C (tr)
AT (1) ATE255562T1 (tr)
AU (1) AU781283B2 (tr)
BR (1) BR9814476A (tr)
CA (1) CA2315835C (tr)
CZ (1) CZ297132B6 (tr)
DE (1) DE69820301T2 (tr)
DK (1) DK1082304T3 (tr)
ES (1) ES2210853T3 (tr)
HU (1) HU228112B1 (tr)
IL (1) IL136828A (tr)
IT (1) IT1297140B1 (tr)
PL (1) PL197768B1 (tr)
PT (1) PT1082304E (tr)
SK (1) SK284777B6 (tr)
TR (1) TR200001867T2 (tr)
WO (1) WO1999033797A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113474354A (zh) * 2019-02-28 2021-10-01 国立大学法人东京工业大学 酰胺的制造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1210673B (it) * 1982-02-26 1989-09-20 Medosan Ind Biochimi Antinfiammatoria amidi pirrolacetiche ad attivita'
IT1148117B (it) * 1982-03-05 1986-11-26 Medosan Ind Biochimi Attivita'antiflogistica,analgesica,antipiretica,mucolitica e seda tiva della tosse dell'1 metil-5-p-tolilpirrol-2-acetato di 2'metossi-fenile
IT1197688B (it) * 1983-07-29 1988-12-06 Medosan Ind Biochimi Attivita' antiflogistica,analgesica,antipiretica ed antiaggregante piastrinica di 1-metil-5-metilbenzoilpirrol-2-acetamido acetanilidi
IT1278144B1 (it) * 1995-07-14 1997-11-17 Medosan Ricerca Srl Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla secrezione gastrica e quindi gastroprotettivo.
ATE237326T1 (de) 1997-08-08 2003-05-15 Medosan Ricerca Srl Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrro -2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörung

Also Published As

Publication number Publication date
CN1283185A (zh) 2001-02-07
DE69820301D1 (de) 2004-01-15
JP4693236B2 (ja) 2011-06-01
CZ297132B6 (cs) 2006-09-13
PT1082304E (pt) 2004-04-30
DK1082304T3 (da) 2004-04-05
IL136828A (en) 2005-08-31
SK284777B6 (sk) 2005-11-03
JP2001527064A (ja) 2001-12-25
EP1082304A1 (en) 2001-03-14
AU781283B2 (en) 2005-05-12
CA2315835C (en) 2008-03-25
ATE255562T1 (de) 2003-12-15
SK8952000A3 (en) 2000-12-11
DE69820301T2 (de) 2004-10-14
HU228112B1 (en) 2012-11-28
PL197768B1 (pl) 2008-04-30
CZ20002336A3 (cs) 2000-12-13
HUP0101025A1 (hu) 2001-08-28
PL341424A1 (en) 2001-04-09
HK1035717A1 (en) 2001-12-07
BR9814476A (pt) 2000-10-10
CA2315835A1 (en) 1999-07-08
KR20010033497A (ko) 2001-04-25
IL136828A0 (en) 2001-06-14
IT1297140B1 (it) 1999-08-03
US6288241B1 (en) 2001-09-11
AU1782899A (en) 1999-07-19
ITRM970811A1 (it) 1999-06-24
ES2210853T3 (es) 2004-07-01
WO1999033797A1 (en) 1999-07-08
KR100554704B1 (ko) 2006-02-24
EP1082304B1 (en) 2003-12-03
HUP0101025A3 (en) 2001-09-28
CN1200930C (zh) 2005-05-11

Similar Documents

Publication Publication Date Title
NO179639C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser
NO177387C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive imidazo-kondenserte, 6-leddede, heterocykliske forbindelser
FI875681L (fi) Menetelmä farmaseuttisesti aktiivisten 4-(2,6,6-trimetyyli-sykloheks-1-enyl)-but-3-en-1-ynyylisubstituoitujen yhdisteiden valmistamiseksi
FI871492L (fi) Menetelmä lääkeaineina käyttökelpoisten 2-tiometyyli-substituoitujen 1,4-dihydropyridiinien valmistamiseksi
ATE64739T1 (de) Bis-phosphit-verbindungen.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
IT1195148B (it) Supporto per rotoli
NO863558L (no) Foring for elektrolysecelle.
NO902776L (no) Fremgangsmaate for fremstilling av nye acetylcholinesterase-inhibitorer.
EE9900180A (et) Asendatud 4-bifenüül-4-hüdroksübutaanhappe derivaadid metalloproteaasimaatriksi inhibiitoritena
ID17291A (id) Penghambat matriks metalloprotease oleh asam biaril oksobutirat tersubstitusi
TR28254A (tr) Alfa-pirimidinil akrilik asit türevleri.
NO174892C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte dihydropyrrolizinforbindelser
NO864869L (no) Fremgangsmaate for fremstilling av ikke-aromatiske fluorallylamin mao-inhibitorer.
NO891647L (no) Fremgangsmaate for desodorisering av fettsyreesterblandinger.
TR200001867T2 (tr) 1-Metil-5-p-topluoilpirol-2-asetamidoasetik asit guaiasil esterin yeni kristalin polimorfik biçimi
FI922720A0 (fi) Farmakologiskt aktiva amidkarboxylatderivat.
NO871190D0 (no) Fremgangsmaate for fremstilling av farmakologisk aktive substituerte anilider.
TR199902057T2 (tr) Benzotiazolon bilesiklerinin hazirlanmasi için proses.
FI20040352L (fi) Menetelmä 4-(3-syaanifenyyli)-trifluorimetyyli-5-okso-1,4,5,6,7,8-heksahydrokinoliini-3-karboksyylihapon valmistamiseksi
NO864818D0 (no) Fremgangsmaate for fremstilling av nye terapeutisk virksomme tetrahydroisokinolinderivater.
FI861557A7 (fi) Menetelmä farmakologisesti aktiivisten fosfiiniyhdisteiden valmistamiseksi.
DE3768557D1 (de) Trans-hexahydroterephthalsaeureesterderivate.
ATE212975T1 (de) Carbamoylcarbonsäureamidoxime
NO890644L (no) Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer.